Conivaptan (Compound)

Synonyms:Conivaptan, 210101-16-9, Conivaptan [INN], YM087, Conivaptan (INN), N-[4-(2-methyl-4,5-dihydro-3H-imidazo[4,5-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide, CHEBI:681850, 0NJ98Y462X, 4'-((4,5-dihydro-2-methylimidazo(4,5-d)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide, (1,1'-biphenyl)-2-carboxamide, N-(4-((4,5-dihydro-2-methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)phenyl)-, [1,1'-Biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2-methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-, CONIVAPTAN [MI], CONIVAPTAN [VANDF], CHEMBL1755, CONIVAPTAN [WHO-DD], SCHEMBL49815, UNII-0NJ98Y462X, GTPL2203, BDBM85095, DTXSID80175220, HMS3745C21, BCP07817, PDSP1_001735, PDSP2_001718, AKOS015917893, CAS_151171, DB00872, NSC_151171, NCGC00345881-02, NCGC00345881-03, NCGC00345881-04, NCGC00345881-05, AC-30626, N-{4-[(2-methyl-4,5-dihydroimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl}biphenyl-2-carboxamide, DB-066404, AM20090722, FT-0724257, D07748, AB01565868_02, EN300-6481317, L001073, L001531, Q5161126, Z2588038959, (1,1'-Biphenyl)-2-carboxamide, N-(4-(4,5-dihydro-2-methylimidazo(4,5-d)(1)benzazepin-6(1H)-yl)carbonyl)phenyl)-, 4''-((4,5-dihydro-2-methylimidazo(4,5-D)(1)benzazepin-6(1H)-yl)carbonyl)-2-biphenylcarboxanilide, 4'-[(2-Methyl-1,4,5,6-tetrahydroimidazo[4,5-d][1]benzazepin-6-yl)carbonyl]-2-phenylbenzanilide, N-(4-{4-methyl-3,5,9-triazatricyclo[8.4.0.0,2,6]tetradeca-1(10),2(6),3,11,13-pentaene-9-carbonyl}phenyl)-[1,1'-biphenyl]-2-carboxamide, N-[4-({4-methyl-3,5,9-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),2(6),3,11,13-pentaen-9-yl}carbonyl)phenyl]-2-phenylbenzamide, N-[4-(2-methyl4,5-dihydro-3H-imidazo[5,4-d][1]benzazepine-6-carbonyl)phenyl]-2-phenylbenzamide, N-[4-[(4,5-Dihydro-2-methylimidazo[4,5-d][benzazepin-6(1H)-yl)carbonyl]phenyl-[1,1'-biphenyl]-2-carboxamide hydrochloride

Pubchem:PUBCHEM:151171

Id:3c4849d0-64af-502f-aa2c-34be1988e5c4

Description:nan